By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Akonni Biosystems has raised about $935,000 of a targeted $20 million offering, the molecular diagnostics firm disclosed in a document filed with the US Securities and Exchange Commission.

The raise is in the form of equity, it said. The company said three investors participated in the round but did not identify them. It also did not provide an intended use of the proceeds and did not respond to a request for comment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: map of human protein interactions, mutant phenotype variability in organisms of the same species from different genetic backgrounds, and more.

Critics call the Fred Hutchinson Cancer Research Center's Gary Gilliland's prediction of cancer cures within 10 years "out of touch with reality" and "irresponsible."

Ivan Oransky discusses the need for reproducibility research at The Conversation.

The San Diego Union-Tribune posts videos from Biocom's Speaker Series with Illumina's Jay Flatley, who discusses Roche's failed hostile takeover bid.